DSM-Firmenich agreed to sell its animal nutrition business to CVC Capital Partners for $2.6 billion, completing a strategic pivot toward human-focused health markets. The Dutch-Swiss specialty chemicals maker will now concentrate entirely on human nutrition, health, and beauty products after divesting its last major animal feed operation.
The deal accelerates DSM-Firmenich's transformation from a diversified materials company to a pure-play health sciences firm. Executives have been reshaping the business since the 2022 merger that created the entity, shedding non-core units to prioritize faster-growing consumer health segments. Private equity firm CVC gains control of a global animal nutrition operation supplying livestock producers.
This transaction reflects broader industry trends as chemical companies streamline portfolios. Investors will monitor how DSM-Firmenich reallocates capital from the sale toward innovation in vitamins, fragrances, and food supplements. CVC plans to operate the acquired business as a standalone entity called Animal Nutrition & Health.
Quick Fact: The deal values DSM-Firmenich's animal nutrition unit at $2.6 billion.
Source: WSJ.com: US Business · Summarized by HeadlinesBriefing